Last April 11, 2024, the Philippine healthcare sector marked a historic milestone with the inauguration of the Healthway Cancer Care Hospital (HCCH). Spearheaded by AC Health and its dedicated arm, Healthway Medical Network (HMN), this visionary initiative addresses the escalating demand for specialized cancer care in the country.

At an exclusive roundtable interview and press tour, AC Health President and CEO, Paolo Borromeo and Healthway Medical Network President and CEO, Jaime Ysmael, unveiled HCCH’s transformative vision and mission. Esteemed medical leaders, including Dr. Manuel Francisco Roxas, Dr. Conrado Gabriel Lorenzo III, Dr. Gaudencio Vega, and Dr. Daniel Alonzo, offered their insights, emphasizing HCCH’s unwavering commitment to clinical excellence.

As the Philippines’ inaugural comprehensive cancer care facility, HCCH provides a holistic spectrum of services—from diagnostic consultations and cutting-edge imaging to advanced chemotherapy, radiation therapy, and surgical interventions. Within its initial months of operation, HCCH has already served hundreds of patients, addressing a diverse range of cancers, such as colorectal, breast, lung, and head and neck malignancies, catering to individuals across all age brackets.

HCCH places paramount importance on patient-centric care, boasting state-of-the-art amenities, including a 100-bed capacity and specialized outpatient units. Leveraging advanced imaging technologies, the hospital stands at the vanguard of early cancer detection, thereby optimizing treatment efficacy and patient outcomes.

In acknowledgment of the financial challenges that often hinder cancer treatment in the Philippines, HCCH is committed to offering cost-effective rates for cancer screening, diagnostics, and treatment. Through strategic collaborations with industry frontrunners like Siemens Healthineers, Varian, Roche, AstraZeneca, and MSD, HCCH delivers unparalleled diagnostic precision and therapeutic effectiveness, all while upholding affordability. Excitingly, the hospital plans to roll out PhilHealth Z-benefit packages tailored for colorectal and breast cancer, further underscoring its dedication to accessible healthcare.

With the unwavering support of the Ayala Group—a stalwart in the healthcare landscape—HCCH aspires to revolutionize cancer care in the Philippines. Through its pledge to specialization, accessibility, and affordability, HCCH stands ready to serve as a guiding light of hope and healing for cancer patients nationwide.